Jörg Pohl
-
- Chemotherapy-induced organ toxicity mitigation 6
- Pharmacology top 10%
-
- Sulfur Compounds in Biology 2
-
- Genomics, phytochemicals, and oxidative stress 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Organophosphorus compounds synthesis 2
- Synthetic Organic Chemistry Methods 1
-
- Chemical Reactions and Isotopes 2
- Co-authors
- N BrockJurij StekarW ScheefUlf NiemeyerC M CastledenAnthony M. HeagertyA HedgesSten Orrenius
- Journals
- Cancer Treatment Reviews (2 papers)Tectonophysics (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Jörg Pohl
15 papers receiving 629 citations
Peers
Comparison fields: 5 of 100
- Pathology and Forensic Medicine 236
- Pharmacology 63
- Oncology 190
- Biochemistry 40
- Hematology 52
Countries citing papers authored by Jörg Pohl
This map shows the geographic impact of Jörg Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Pohl more than expected).
Fields of papers citing papers by Jörg Pohl
This network shows the impact of papers produced by Jörg Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Pohl. The network helps show where Jörg Pohl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jörg Pohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 17 | |
| 2 | 2011 | 1 | |
| 3 | 2000 | 23 | |
| 4 | 2000 | 25 | |
| 5 | 1999 | 50 | |
| 6 | 1996 | 25 | |
| 7 | 1987 | 2 | |
| 8 | 1986 | 4 | |
| 9 | 1985 | 31 | |
| 10 | Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. | 1983 | 72 |
| 11 | 1983 | 66 | |
| 12 | 1982 | 111 | |
| 13 | 1981 | 69 | |
| 14 | 1981 | 95 | |
| 15 | 1981 | 96 |
About Jörg Pohl
Jörg Pohl is a scholar working on Biochemistry, Pathology and Forensic Medicine, Pharmaceutical Science, Analytical Chemistry and Public Health, Environmental and Occupational Health, having authored 15 papers that have together received 687 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (6 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Sulfur Compounds in Biology (2 papers), Organophosphorus compounds synthesis (2 papers), Chemical Reactions and Isotopes (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Synthetic Organic Chemistry Methods (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (236 citations), Pharmacology (63 citations), Oncology (190 citations), Biochemistry (40 citations) and Hematology (52 citations). Jörg Pohl has collaborated with scholars based in Germany, United States and France. Frequent co-authors include N Brock, Jurij Stekar, W Scheef, Ulf Niemeyer, C M Castleden, Anthony M. Heagerty, A Hedges, Sten Orrenius, Robert Martino and Kari Ormstad. Their work appears in journals such as Cancer Treatment Reviews, Tectonophysics, Investigational New Drugs, Journal of Medicinal Chemistry and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.